Transarterial chemoembolization combined with atezolizumab plus bevacizumab versus transarterial chemoembolization combined with lenvatinib plus sintilimab as first-line therapy for advanced hepatocellular carcinoma.

Authors: Ningning Zhang, Yawei Du, Yuexi Yu, Qiang Wu, Wei Bai, Wei Zhang, Shuwen Zhang, Wenwen Zhu, Hao Yu, Xuanchen Liu, Ming Luo, Huiru Liu, Yiyan Zhang, Kaipeng Liu, Yiming Huo, Guohong Han, Haipeng Yu, Jihui Hao, Wei Lu

Published: 2025-05-28

DOI: 10.1200/jco.2025.43.16_suppl.e16223

Source: Full article

---

Abstract

e16223